Halozyme Therapeutics, Inc. HALO
HALO
Halozyme Therapeutics, Inc. FOLD
Amicus Therapeutics, Inc. INCY
Incyte Corporation DNLI
Denali Therapeutics Inc. ARGX
argenx SE HRMY
Harmony Biosciences Holdings, Inc. AGIO
Agios Pharmaceuticals, Inc. PTCT
PTC Therapeutics, Inc. ALNY
Alnylam Pharmaceuticals, Inc. CLDX
Celldex Therapeutics, Inc.
Halozyme Therapeutics, Inc. FOLD
Amicus Therapeutics, Inc. INCY
Incyte Corporation DNLI
Denali Therapeutics Inc. ARGX
argenx SE HRMY
Harmony Biosciences Holdings, Inc. AGIO
Agios Pharmaceuticals, Inc. PTCT
PTC Therapeutics, Inc. ALNY
Alnylam Pharmaceuticals, Inc. CLDX
Celldex Therapeutics, Inc.
Performance
| Periode | HALO | FOLD | INCY | DNLI | ARGX | HRMY | AGIO | PTCT | ALNY | CLDX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 6.44 % | 28.09 % | 47.35 % | 21.02 % | 37.18 % | -9.02 % | 52.10 % | 54.09 % | 93.53 % | 58.97 % |
| YTD | 33.51 % | -10.85 % | 20.52 % | -26.25 % | 28.50 % | -23.80 % | 27.54 % | 44.35 % | 96.97 % | 3.80 % |
| 1Y | 18.81 % | -20.35 % | 28.06 % | -42.71 % | 46.61 % | -25.20 % | -1.62 % | 69.21 % | 62.42 % | -11.59 % |
| 3Y | 50.47 % | -22.28 % | 24.13 % | -51.35 % | 130.43 % | -43.10 % | 44.73 % | 29.28 % | 148.58 % | -12.26 % |
| 5Y | 124.87 % | -47.20 % | -14.23 % | -64.79 % | 184.08 % | -21.25 % | 14.01 % | 21.34 % | 213.03 % | 58.50 % |
| 10Y | 359.50 % | 12.16 % | -20.95 % | -28.34 % | 3 364.87 % | -28.29 % | -44.82 % | 110.72 % | 458.51 % | -86.08 % |
| From the beginning | 1 408.24 % | -42.48 % | 4 369.33 % | -28.34 % | 3 364.87 % | -28.29 % | 29.83 % | 301.64 % | 7 556.49 % | -96.95 % |